48North Cannabis Competitors

MediPharm Labs (TSE:LABS) and 48North Cannabis (CVE:NRTH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings for MediPharm Labs and 48North Cannabis, as provided by MarketBeat.

MediPharm Labs currently has a consensus target price of C$1.53, indicating a potential upside of 229.03%. Given MediPharm Labs' higher probable upside, equities analysts plainly believe MediPharm Labs is more favorable than 48North Cannabis.

Earnings and Valuation

This table compares MediPharm Labs and 48North Cannabis' revenue, earnings per share and valuation.

48North Cannabis has lower revenue, but higher earnings than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than 48North Cannabis, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares MediPharm Labs and 48North Cannabis' net margins, return on equity and return on assets.

Summary

MediPharm Labs beats 48North Cannabis on 4 of the 7 factors compared between the two stocks.

Khiron Life Sciences (CVE:KHRN) and 48North Cannabis (CVE:NRTH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, valuation, earnings and institutional ownership.

Valuation & Earnings

This table compares Khiron Life Sciences and 48North Cannabis' top-line revenue, earnings per share and valuation.

Khiron Life Sciences has higher earnings, but lower revenue than 48North Cannabis. Khiron Life Sciences is trading at a lower price-to-earnings ratio than 48North Cannabis, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Khiron Life Sciences and 48North Cannabis, as reported by MarketBeat.com.

Khiron Life Sciences currently has a consensus target price of C$1.20, indicating a potential upside of 147.42%. Given Khiron Life Sciences' higher probable upside, analysts clearly believe Khiron Life Sciences is more favorable than 48North Cannabis.

Profitability

This table compares Khiron Life Sciences and 48North Cannabis' net margins, return on equity and return on assets.

Summary

Khiron Life Sciences beats 48North Cannabis on 3 of the 5 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and 48North Cannabis (CVE:NRTH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation.

Profitability

This table compares Delta 9 Cannabis and 48North Cannabis' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Delta 9 Cannabis and 48North Cannabis' top-line revenue, earnings per share (EPS) and valuation.

Delta 9 Cannabis has higher revenue and earnings than 48North Cannabis. Delta 9 Cannabis is trading at a lower price-to-earnings ratio than 48North Cannabis, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for Delta 9 Cannabis and 48North Cannabis, as reported by MarketBeat.

Delta 9 Cannabis presently has a consensus price target of C$1.10, suggesting a potential upside of 92.98%. Given Delta 9 Cannabis' higher possible upside, equities research analysts clearly believe Delta 9 Cannabis is more favorable than 48North Cannabis.

Summary

Delta 9 Cannabis beats 48North Cannabis on 5 of the 7 factors compared between the two stocks.

Meta Growth (CVE:META) and 48North Cannabis (CVE:NRTH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation & Earnings

This table compares Meta Growth and 48North Cannabis' gross revenue, earnings per share (EPS) and valuation.

Meta Growth has higher revenue and earnings than 48North Cannabis. Meta Growth is trading at a lower price-to-earnings ratio than 48North Cannabis, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Meta Growth and 48North Cannabis' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Meta Growth and 48North Cannabis, as provided by MarketBeat.com.

Summary

Meta Growth beats 48North Cannabis on 3 of the 5 factors compared between the two stocks.

48North Cannabis (CVE:NRTH) and (CSI) (CNSX:CSI) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Earnings & Valuation

This table compares 48North Cannabis and (CSI)'s gross revenue, earnings per share (EPS) and valuation.

(CSI) has lower revenue, but higher earnings than 48North Cannabis.

Analyst Ratings

This is a breakdown of current ratings and target prices for 48North Cannabis and (CSI), as provided by MarketBeat.com.

Profitability

This table compares 48North Cannabis and (CSI)'s net margins, return on equity and return on assets.

Summary

48North Cannabis beats (CSI) on 1 of the 1 factors compared between the two stocks.

28896 (CNSX:BAMM) and 48North Cannabis (CVE:NRTH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability.

Analyst Ratings

This is a summary of recent ratings and recommmendations for 28896 and 48North Cannabis, as reported by MarketBeat.com.

Profitability

This table compares 28896 and 48North Cannabis' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares 28896 and 48North Cannabis' revenue, earnings per share (EPS) and valuation.

28896 has higher earnings, but lower revenue than 48North Cannabis.

Summary

48North Cannabis beats 28896 on 1 of the 1 factors compared between the two stocks.